Detalhe da pesquisa
1.
Evolving applications of liquid biopsies in gastrointestinal cancers.
Clin Adv Hematol Oncol
; 22(1): 43-54, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294740
2.
A first-in-human study of the novel metabolism-based anti-cancer agent SM-88 in subjects with advanced metastatic cancer.
Invest New Drugs
; 38(2): 392-401, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929156
3.
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Invest New Drugs
; 38(3): 800-811, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297636
4.
Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study.
Support Care Cancer
; 26(2): 605-613, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28914366
5.
Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC).
Int J Radiat Oncol Biol Phys
; 118(2): 362-367, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717786
6.
Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer.
J Gastrointest Cancer
; 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347342
7.
Perioperative therapy landscape for locally advanced, resectable esophageal cancer: an updated literature review.
J Thorac Dis
; 15(6): 3466-3487, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37426147
8.
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFß Signaling Pathways and COP1 in Metastasis.
Cancers (Basel)
; 15(6)2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980717
9.
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial.
EClinicalMedicine
; 58: 101897, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969338
10.
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.
J Clin Oncol
; 41(11): 2007-2019, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521097
11.
The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways.
Cancers (Basel)
; 14(11)2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681599
12.
Cytotoxic Chemotherapy in Advanced Pancreatic Cancer.
Hematol Oncol Clin North Am
; 36(5): 1011-1018, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154782
13.
The Role of Immunotherapy in Pancreatic Cancer.
Curr Oncol
; 29(10): 6864-6892, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36290818
14.
Gastric carcinoma's primary presentation as multiple cutaneous nodules throughout the body.
Cancer Treat Res Commun
; 31: 100532, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217487
15.
The current state of molecular profiling in gastrointestinal malignancies.
Biol Direct
; 17(1): 15, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668531
16.
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Cancer Med
; 11(22): 4169-4181, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499204
17.
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513.
Clin Cancer Res
; 27(23): 6314-6322, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580114
18.
MEK inhibitors in non-V600 BRAF mutations and fusions.
Oncotarget
; 11(44): 3900-3903, 2020 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216832
19.
Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
Clin Colorectal Cancer
; 19(3): e124-e128, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409226
20.
Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131).
Clin Cancer Res
; 26(8): 1812-1819, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924734